Industry: Medical Devices & Consumables
Published Date: 2024-09-25
Pages: 100 Pages
Report ld: 3328805
Request Sample
Customized Report
Total Prostate-Specific Antigen (PSA) Assay Kit is a diagnostic tool used to measure the level of total prostate-specific antigen (PSA) in the blood. PSA is a protein secreted by prostate cells, and elevated levels may be associated with prostate conditions such as benign prostatic hyperplasia or prostate cancer. The assay kit is commonly used for screening prostate health, monitoring disease progression, and evaluating treatment efficacy.
The global Total Prostate Specific Antigen Assay Kit market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Total Prostate Specific Antigen Assay Kit is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Total Prostate Specific Antigen Assay Kit is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Total Prostate Specific Antigen Assay Kit include Langfeng Biotech, Mesai Biotech, Coring, Bluestar Forensic, Independent Forensics, Thomas Scientific, Abacus Diagnostics, Abcam, SERATEC PSA Semiquant, Antu Biotech, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Total Prostate Specific Antigen Assay Kit, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Total Prostate Specific Antigen Assay Kit.
The Total Prostate Specific Antigen Assay Kit market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Total Prostate Specific Antigen Assay Kit market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Total Prostate Specific Antigen Assay Kit manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Langfeng Biotech
Mesai Biotech
Coring
Bluestar Forensic
Independent Forensics
Thomas Scientific
Abacus Diagnostics
Abcam
SERATEC PSA Semiquant
Antu Biotech
Hanbaikang Biotech
Bioscience Biotech
SonaCare Medical
Fujirebio
Boston Scientific
Siemens Healthcare Diagnostics Products
NeoTract
Beckman Coulter
Tosoh
Roche Diagnostics
Segment by Type
ELISA
CLIA
Other
Segment by Application
Forensic Medicine
Medical Testing
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Total Prostate Specific Antigen Assay Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Total Prostate Specific Antigen Assay Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Total Prostate Specific Antigen Assay Kit Market Overview
1.1 Product Definition
1.2 Total Prostate Specific Antigen Assay Kit by Type
1.2.1 Global Total Prostate Specific Antigen Assay Kit Market Value Comparison by Type (2024-2030)
1.2.2 ELISA
1.2.3 CLIA
1.2.4 Other
1.3 Total Prostate Specific Antigen Assay Kit by Application
1.3.1 Global Total Prostate Specific Antigen Assay Kit Market Value by Application (2024-2030)
1.3.2 Forensic Medicine
1.3.3 Medical Testing
1.4 Global Total Prostate Specific Antigen Assay Kit Market Size Estimates and Forecasts
1.4.1 Global Total Prostate Specific Antigen Assay Kit Revenue 2019-2030
1.4.2 Global Total Prostate Specific Antigen Assay Kit Sales 2019-2030
1.4.3 Global Total Prostate Specific Antigen Assay Kit Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Total Prostate Specific Antigen Assay Kit Market Competition by Manufacturers
2.1 Global Total Prostate Specific Antigen Assay Kit Sales Market Share by Manufacturers (2019-2024)
2.2 Global Total Prostate Specific Antigen Assay Kit Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Total Prostate Specific Antigen Assay Kit Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Total Prostate Specific Antigen Assay Kit, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Total Prostate Specific Antigen Assay Kit, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Total Prostate Specific Antigen Assay Kit, Product Type & Application
2.7 Global Key Manufacturers of Total Prostate Specific Antigen Assay Kit, Date of Enter into This Industry
2.8 Global Total Prostate Specific Antigen Assay Kit Market Competitive Situation and Trends
2.8.1 Global Total Prostate Specific Antigen Assay Kit Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Total Prostate Specific Antigen Assay Kit Players Market Share by Revenue
2.8.3 Global Total Prostate Specific Antigen Assay Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Total Prostate Specific Antigen Assay Kit Market Scenario by Region
3.1 Global Total Prostate Specific Antigen Assay Kit Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Total Prostate Specific Antigen Assay Kit Sales by Region: 2019-2030
3.2.1 Global Total Prostate Specific Antigen Assay Kit Sales by Region: 2019-2024
3.2.2 Global Total Prostate Specific Antigen Assay Kit Sales by Region: 2025-2030
3.3 Global Total Prostate Specific Antigen Assay Kit Revenue by Region: 2019-2030
3.3.1 Global Total Prostate Specific Antigen Assay Kit Revenue by Region: 2019-2024
3.3.2 Global Total Prostate Specific Antigen Assay Kit Revenue by Region: 2025-2030
3.4 North America Total Prostate Specific Antigen Assay Kit Market Facts & Figures by Country
3.4.1 North America Total Prostate Specific Antigen Assay Kit Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Total Prostate Specific Antigen Assay Kit Sales by Country (2019-2030)
3.4.3 North America Total Prostate Specific Antigen Assay Kit Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Total Prostate Specific Antigen Assay Kit Market Facts & Figures by Country
3.5.1 Europe Total Prostate Specific Antigen Assay Kit Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Total Prostate Specific Antigen Assay Kit Sales by Country (2019-2030)
3.5.3 Europe Total Prostate Specific Antigen Assay Kit Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Total Prostate Specific Antigen Assay Kit Market Facts & Figures by Region
3.6.1 Asia Pacific Total Prostate Specific Antigen Assay Kit Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Total Prostate Specific Antigen Assay Kit Sales by Region (2019-2030)
3.6.3 Asia Pacific Total Prostate Specific Antigen Assay Kit Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Total Prostate Specific Antigen Assay Kit Market Facts & Figures by Country
3.7.1 Latin America Total Prostate Specific Antigen Assay Kit Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Total Prostate Specific Antigen Assay Kit Sales by Country (2019-2030)
3.7.3 Latin America Total Prostate Specific Antigen Assay Kit Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Total Prostate Specific Antigen Assay Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa Total Prostate Specific Antigen Assay Kit Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Total Prostate Specific Antigen Assay Kit Sales by Country (2019-2030)
3.8.3 Middle East and Africa Total Prostate Specific Antigen Assay Kit Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Total Prostate Specific Antigen Assay Kit Sales by Type (2019-2030)
4.1.1 Global Total Prostate Specific Antigen Assay Kit Sales by Type (2019-2024)
4.1.2 Global Total Prostate Specific Antigen Assay Kit Sales by Type (2025-2030)
4.1.3 Global Total Prostate Specific Antigen Assay Kit Sales Market Share by Type (2019-2030)
4.2 Global Total Prostate Specific Antigen Assay Kit Revenue by Type (2019-2030)
4.2.1 Global Total Prostate Specific Antigen Assay Kit Revenue by Type (2019-2024)
4.2.2 Global Total Prostate Specific Antigen Assay Kit Revenue by Type (2025-2030)
4.2.3 Global Total Prostate Specific Antigen Assay Kit Revenue Market Share by Type (2019-2030)
4.3 Global Total Prostate Specific Antigen Assay Kit Price by Type (2019-2030)
5 Segment by Application
5.1 Global Total Prostate Specific Antigen Assay Kit Sales by Application (2019-2030)
5.1.1 Global Total Prostate Specific Antigen Assay Kit Sales by Application (2019-2024)
5.1.2 Global Total Prostate Specific Antigen Assay Kit Sales by Application (2025-2030)
5.1.3 Global Total Prostate Specific Antigen Assay Kit Sales Market Share by Application (2019-2030)
5.2 Global Total Prostate Specific Antigen Assay Kit Revenue by Application (2019-2030)
5.2.1 Global Total Prostate Specific Antigen Assay Kit Revenue by Application (2019-2024)
5.2.2 Global Total Prostate Specific Antigen Assay Kit Revenue by Application (2025-2030)
5.2.3 Global Total Prostate Specific Antigen Assay Kit Revenue Market Share by Application (2019-2030)
5.3 Global Total Prostate Specific Antigen Assay Kit Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Langfeng Biotech
6.1.1 Langfeng Biotech Company Information
6.1.2 Langfeng Biotech Description and Business Overview
6.1.3 Langfeng Biotech Total Prostate Specific Antigen Assay Kit Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Langfeng Biotech Total Prostate Specific Antigen Assay Kit Product Portfolio
6.1.5 Langfeng Biotech Recent Developments/Updates
6.2 Mesai Biotech
6.2.1 Mesai Biotech Company Information
6.2.2 Mesai Biotech Description and Business Overview
6.2.3 Mesai Biotech Total Prostate Specific Antigen Assay Kit Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mesai Biotech Total Prostate Specific Antigen Assay Kit Product Portfolio
6.2.5 Mesai Biotech Recent Developments/Updates
6.3 Coring
6.3.1 Coring Company Information
6.3.2 Coring Description and Business Overview
6.3.3 Coring Total Prostate Specific Antigen Assay Kit Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Coring Total Prostate Specific Antigen Assay Kit Product Portfolio
6.3.5 Coring Recent Developments/Updates
6.4 Bluestar Forensic
6.4.1 Bluestar Forensic Company Information
6.4.2 Bluestar Forensic Description and Business Overview
6.4.3 Bluestar Forensic Total Prostate Specific Antigen Assay Kit Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bluestar Forensic Total Prostate Specific Antigen Assay Kit Product Portfolio
6.4.5 Bluestar Forensic Recent Developments/Updates
6.5 Independent Forensics
6.5.1 Independent Forensics Company Information
6.5.2 Independent Forensics Description and Business Overview
6.5.3 Independent Forensics Total Prostate Specific Antigen Assay Kit Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Independent Forensics Total Prostate Specific Antigen Assay Kit Product Portfolio
6.5.5 Independent Forensics Recent Developments/Updates
6.6 Thomas Scientific
6.6.1 Thomas Scientific Company Information
6.6.2 Thomas Scientific Description and Business Overview
6.6.3 Thomas Scientific Total Prostate Specific Antigen Assay Kit Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Thomas Scientific Total Prostate Specific Antigen Assay Kit Product Portfolio
6.6.5 Thomas Scientific Recent Developments/Updates
6.7 Abacus Diagnostics
6.7.1 Abacus Diagnostics Company Information
6.7.2 Abacus Diagnostics Description and Business Overview
6.7.3 Abacus Diagnostics Total Prostate Specific Antigen Assay Kit Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Abacus Diagnostics Total Prostate Specific Antigen Assay Kit Product Portfolio
6.7.5 Abacus Diagnostics Recent Developments/Updates
6.8 Abcam
6.8.1 Abcam Company Information
6.8.2 Abcam Description and Business Overview
6.8.3 Abcam Total Prostate Specific Antigen Assay Kit Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Abcam Total Prostate Specific Antigen Assay Kit Product Portfolio
6.8.5 Abcam Recent Developments/Updates
6.9 SERATEC PSA Semiquant
6.9.1 SERATEC PSA Semiquant Company Information
6.9.2 SERATEC PSA Semiquant Description and Business Overview
6.9.3 SERATEC PSA Semiquant Total Prostate Specific Antigen Assay Kit Sales, Revenue and Gross Margin (2019-2024)
6.9.4 SERATEC PSA Semiquant Total Prostate Specific Antigen Assay Kit Product Portfolio
6.9.5 SERATEC PSA Semiquant Recent Developments/Updates
6.10 Antu Biotech
6.10.1 Antu Biotech Company Information
6.10.2 Antu Biotech Description and Business Overview
6.10.3 Antu Biotech Total Prostate Specific Antigen Assay Kit Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Antu Biotech Total Prostate Specific Antigen Assay Kit Product Portfolio
6.10.5 Antu Biotech Recent Developments/Updates
6.11 Hanbaikang Biotech
6.11.1 Hanbaikang Biotech Company Information
6.11.2 Hanbaikang Biotech Description and Business Overview
6.11.3 Hanbaikang Biotech Total Prostate Specific Antigen Assay Kit Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hanbaikang Biotech Total Prostate Specific Antigen Assay Kit Product Portfolio
6.11.5 Hanbaikang Biotech Recent Developments/Updates
6.12 Bioscience Biotech
6.12.1 Bioscience Biotech Company Information
6.12.2 Bioscience Biotech Description and Business Overview
6.12.3 Bioscience Biotech Total Prostate Specific Antigen Assay Kit Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Bioscience Biotech Total Prostate Specific Antigen Assay Kit Product Portfolio
6.12.5 Bioscience Biotech Recent Developments/Updates
6.13 SonaCare Medical
6.13.1 SonaCare Medical Company Information
6.13.2 SonaCare Medical Description and Business Overview
6.13.3 SonaCare Medical Total Prostate Specific Antigen Assay Kit Sales, Revenue and Gross Margin (2019-2024)
6.13.4 SonaCare Medical Total Prostate Specific Antigen Assay Kit Product Portfolio
6.13.5 SonaCare Medical Recent Developments/Updates
6.14 Fujirebio
6.14.1 Fujirebio Company Information
6.14.2 Fujirebio Description and Business Overview
6.14.3 Fujirebio Total Prostate Specific Antigen Assay Kit Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Fujirebio Total Prostate Specific Antigen Assay Kit Product Portfolio
6.14.5 Fujirebio Recent Developments/Updates
6.15 Boston Scientific
6.15.1 Boston Scientific Company Information
6.15.2 Boston Scientific Description and Business Overview
6.15.3 Boston Scientific Total Prostate Specific Antigen Assay Kit Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Boston Scientific Total Prostate Specific Antigen Assay Kit Product Portfolio
6.15.5 Boston Scientific Recent Developments/Updates
6.16 Siemens Healthcare Diagnostics Products
6.16.1 Siemens Healthcare Diagnostics Products Company Information
6.16.2 Siemens Healthcare Diagnostics Products Description and Business Overview
6.16.3 Siemens Healthcare Diagnostics Products Total Prostate Specific Antigen Assay Kit Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Siemens Healthcare Diagnostics Products Total Prostate Specific Antigen Assay Kit Product Portfolio
6.16.5 Siemens Healthcare Diagnostics Products Recent Developments/Updates
6.17 NeoTract
6.17.1 NeoTract Company Information
6.17.2 NeoTract Description and Business Overview
6.17.3 NeoTract Total Prostate Specific Antigen Assay Kit Sales, Revenue and Gross Margin (2019-2024)
6.17.4 NeoTract Total Prostate Specific Antigen Assay Kit Product Portfolio
6.17.5 NeoTract Recent Developments/Updates
6.18 Beckman Coulter
6.18.1 Beckman Coulter Company Information
6.18.2 Beckman Coulter Description and Business Overview
6.18.3 Beckman Coulter Total Prostate Specific Antigen Assay Kit Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Beckman Coulter Total Prostate Specific Antigen Assay Kit Product Portfolio
6.18.5 Beckman Coulter Recent Developments/Updates
6.19 Tosoh
6.19.1 Tosoh Company Information
6.19.2 Tosoh Description and Business Overview
6.19.3 Tosoh Total Prostate Specific Antigen Assay Kit Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Tosoh Total Prostate Specific Antigen Assay Kit Product Portfolio
6.19.5 Tosoh Recent Developments/Updates
6.20 Roche Diagnostics
6.20.1 Roche Diagnostics Company Information
6.20.2 Roche Diagnostics Description and Business Overview
6.20.3 Roche Diagnostics Total Prostate Specific Antigen Assay Kit Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Roche Diagnostics Total Prostate Specific Antigen Assay Kit Product Portfolio
6.20.5 Roche Diagnostics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Total Prostate Specific Antigen Assay Kit Industry Chain Analysis
7.2 Total Prostate Specific Antigen Assay Kit Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Total Prostate Specific Antigen Assay Kit Production Mode & Process
7.4 Total Prostate Specific Antigen Assay Kit Sales and Marketing
7.4.1 Total Prostate Specific Antigen Assay Kit Sales Channels
7.4.2 Total Prostate Specific Antigen Assay Kit Distributors
7.5 Total Prostate Specific Antigen Assay Kit Customers
8 Total Prostate Specific Antigen Assay Kit Market Dynamics
8.1 Total Prostate Specific Antigen Assay Kit Industry Trends
8.2 Total Prostate Specific Antigen Assay Kit Market Drivers
8.3 Total Prostate Specific Antigen Assay Kit Market Challenges
8.4 Total Prostate Specific Antigen Assay Kit Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Total Prostate Specific Antigen Assay Kit market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 178
USD 4900.00
(Single User License)
The global Total Prostate Specific Antigen Assay Kit market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 107
USD 4250.00
(Single User License)
The global market for Total Prostate Specific Antigen Assay Kit was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 145
USD 3950.00
(Single User License)
The global Total Prostate Specific Antigen Assay Kit market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 135
USD 2900.00
(Single User License)
The global Total Prostate Specific Antigen Assay Kit market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 172
USD 4900.00
(Single User License)
The global Total Prostate Specific Antigen Assay Kit market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 106
USD 4250.00
(Single User License)
The global market for Total Prostate Specific Antigen Assay Kit was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 145
USD 3950.00
(Single User License)
The global market for Total Prostate Specific Antigen Assay Kit was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 101
USD 2900.00
(Single User License)
Total Prostate-Specific Antigen (PSA) Assay Kit is a diagnostic tool used to measure the level of total prostate-specific antigen (PSA) in the blood. PSA is a protein secreted by prostate cells, and elevated levels may be associated with prostate conditions such as benign prostatic hyperplasia or prostate cancer. The assay kit is commonly used for screening prostate health, monitoring disease progression, and evaluating treatment efficacy.
Published Date: 2024-09-25
Pages: 158
USD 4350.00
(Single User License)
Total Prostate-Specific Antigen (PSA) Assay Kit is a diagnostic tool used to measure the level of total prostate-specific antigen (PSA) in the blood. PSA is a protein secreted by prostate cells, and elevated levels may be associated with prostate conditions such as benign prostatic hyperplasia or prostate cancer. The assay kit is commonly used for screening prostate health, monitoring disease progression, and evaluating treatment efficacy.
Published Date: 2024-09-25
Pages: 185
USD 4900.00
(Single User License)
The global Total Prostate Specific Antigen Assay Kit market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 178
The global Total Prostate Specific Antigen Assay Kit market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 107
The global market for Total Prostate Specific Antigen Assay Kit was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 145
The global Total Prostate Specific Antigen Assay Kit market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 135
The global Total Prostate Specific Antigen Assay Kit market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 172
The global Total Prostate Specific Antigen Assay Kit market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 106
The global market for Total Prostate Specific Antigen Assay Kit was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 145
The global market for Total Prostate Specific Antigen Assay Kit was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 101
Total Prostate-Specific Antigen (PSA) Assay Kit is a diagnostic tool used to measure the level of total prostate-specific antigen (PSA) in the blood. PSA is a protein secreted by prostate cells, and elevated levels may be associated with prostate conditions such as benign prostatic hyperplasia or prostate cancer. The assay kit is commonly used for screening prostate health, monitoring disease progression, and evaluating treatment efficacy.
Published: 2024-09-25
Pages: 158
Total Prostate-Specific Antigen (PSA) Assay Kit is a diagnostic tool used to measure the level of total prostate-specific antigen (PSA) in the blood. PSA is a protein secreted by prostate cells, and elevated levels may be associated with prostate conditions such as benign prostatic hyperplasia or prostate cancer. The assay kit is commonly used for screening prostate health, monitoring disease progression, and evaluating treatment efficacy.
Published: 2024-09-25
Pages: 185
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now